Molina Healthcare Stock Plummets 29% After Earnings Miss
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2026
0mins
Should l Buy MOH?
Source: Benzinga
- Unexpected Quarterly Loss: Molina Healthcare reported an unexpected quarterly loss, causing its stock to plummet 29% in a single day, marking the largest drop since 2012 and indicating significant challenges in profitability.
- Weak 2026 Outlook: The company issued a weak earnings outlook for 2026, which may undermine investor confidence and further pressure the stock price, reflecting market concerns about its future growth potential.
- Strong Overall Market Performance: Despite Molina Healthcare's stock decline, the Dow Jones Industrial Average surged nearly 2% on Friday, reaching a new all-time high, indicating a market preference for value stocks that may overshadow individual stock weaknesses.
- Small Caps Outperform: Small caps showed outstanding performance on Friday, with the Russell 2000 index soaring over 3%, suggesting increased investor confidence in smaller companies, contrasting sharply with Molina's performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOH
Wall Street analysts forecast MOH stock price to rise
14 Analyst Rating
3 Buy
9 Hold
2 Sell
Hold
Current: 142.210
Low
155.00
Averages
180.85
High
250.00
Current: 142.210
Low
155.00
Averages
180.85
High
250.00
About MOH
Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Progress: The U.S. District Court for the Southern District of New York partially denied ASP Isotopes' motion to dismiss, allowing the securities fraud class action to proceed, indicating serious consideration of investor allegations that could lead to significant financial liabilities for the company.
- False Statement Allegations: The lawsuit alleges that the company and its executives made materially false and misleading statements regarding their uranium enrichment technology prior to September 2024, raising approximately $18.6 million without actual testing, which may undermine investor confidence.
- Shareholder Rights Protection: Shareholders who purchased ASP Isotopes securities before September 26, 2024, can seek corporate reforms and fund recovery, highlighting legal avenues available for affected investors to potentially reclaim losses.
- Potential Market Impact: As the lawsuit progresses and may result in liability for the company, investor confidence in ASP Isotopes could wane, negatively impacting its stock price and reflecting market concerns over corporate governance and transparency.
See More
- Decline in Coverage: A KFF survey reveals that approximately 9% of ACA marketplace enrollees lost their insurance after the expiration of subsidies, indicating a direct impact of rising premiums that may lead to more individuals facing healthcare cost burdens.
- Significant Premium Increases: With the lapse of enhanced premium tax credits, average premiums for ACA enrollees are expected to double by 2026, exacerbating financial pressures on households and affecting their spending capabilities.
- Voter Sentiment Shift: The survey indicates that 54% of returning ACA enrollees blame rising healthcare costs on congressional Republicans and Trump, suggesting that healthcare affordability could become a pivotal political issue in the upcoming midterm elections, influencing voter turnout.
- Household Financial Strain: About 55% of ACA enrollees report cutting back on essential expenses like food and clothing to afford healthcare costs, highlighting the profound impact of medical expenses on household finances, which could lead to higher unemployment rates and economic instability.
See More
- Stake Increase: Redwood Capital increased its stake in Molina Healthcare by 51,600 shares in Q4 2026, valued at approximately $8.48 million, indicating confidence in the company despite a 53% decline in its stock price over the past year.
- Holding Position: Following this purchase, Redwood's total holdings in Molina Healthcare reached 110,000 shares, with a quarter-end value of $19.09 million, representing about 2% of Redwood's reportable U.S. equity assets.
- Financial Performance: Despite generating over $45 billion in revenue last year, Molina Healthcare's profitability sharply declined, with adjusted EPS falling to just over $11 from $22.65 the previous year due to rising medical costs and unfavorable contract dynamics.
- Market Outlook: The market anticipates a 2% decline in Molina's premium revenue for 2026, projected at around $42 billion; however, if cost pressures ease, this could present a turnaround opportunity for investors looking for defensive, policy-driven investments.
See More
- Market Expansion: JD.com has officially launched its Joybuy marketplace in the UK and Northern Europe, leveraging its $2.5 billion acquisition of Ceconomy to deploy 60 warehouses for same-day delivery to 15 million households, directly challenging Amazon's regional dominance and showcasing JD's ambitions in international markets.
- Price Competition: The introduction of the “JoyPlus” subscription service at just £3.99 per month significantly undercuts Amazon Prime, aiming to attract price-sensitive consumers, thereby increasing market share and enhancing customer loyalty.
- Logistics Advantage: By controlling its own last-mile delivery service and localized warehouses, JD is attempting to replicate its efficient fulfillment model from China to address domestic competitive pressures and improve overall operational efficiency.
- Electronics Market: The integration of Ceconomy provides Joybuy with an immediate foothold in the high-margin European electronics sector, expected to challenge Amazon's pricing strategies and further drive JD's growth potential in international markets.
See More
- New Investment Disclosure: On February 17, 2026, Solas Capital Management disclosed a new position in Euronet Worldwide by acquiring 73,494 shares valued at $5.59 million at quarter-end, reflecting confidence in the company's growth potential despite recent stock performance.
- Ownership Analysis: This investment represents 3.17% of Solas Capital Management's reportable AUM in its 13F filing, indicating a strategic diversification approach, even as Euronet's stock has declined by 30% over the past year.
- Company Performance Overview: Euronet Worldwide reported $4.24 billion in revenue for 2025, a 6% year-over-year increase, with net income reaching $309 million, showcasing robust fundamentals despite stock underperformance in the competitive payments processing sector.
- Future Growth Expectations: Management anticipates adjusted earnings per share to grow by 10% to 15% in 2026, aligning with trends in digital money transfers and international payment expansions, which may attract further investor interest in the company.
See More
- Campbell's S&P 500 Status: Campbell's, a long-standing member of the S&P 500 since 1957, may risk removal from the index if its stock does not recover significantly.
- Earnings Report Significance: The upcoming earnings report, set to be released before the market opens on Wednesday, will be crucial in influencing the stock's performance in the near future.
See More











